Literature DB >> 33974494

Recurrence of primary cutaneous CD30-positive lymphoproliferative disorder following COVID-19 vaccination.

Caitlin M Brumfiel1, Meera H Patel1, David J DiCaudo1, Allison C Rosenthal2, Mark R Pittelkow1, Aaron R Mangold1.   

Abstract

Entities:  

Keywords:  CD30-positive lymphoproliferative disorder; COVID-19 vaccination; COVID-19 vaccine; Lymphoma; lymphoproliferative disorder; mRNA vaccine

Year:  2021        PMID： 33974494     DOI： 10.1080/10428194.2021.1924371

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  8 in total

1.  New mycosis fungoides-like lymphomatoid reaction following COVID-19 vaccination: A case report.

Authors:  Heidi Oi-Yee Li; Jennifer Lipson
Journal:  SAGE Open Med Case Rep       Date:  2022-10-15

2.  Recurrence of cutaneous T-cell lymphoma post viral vector COVID-19 vaccination.

Authors:  E Panou; V Nikolaou; L Marinos; S Kallambou; P Sidiropoulou; M Gerochristou; A Stratigos
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-10-31       Impact factor: 9.228

3.  Primary cutaneous anaplastic large-cell lymphoma with marked spontaneous regression of organ manifestation after SARS-CoV-2 vaccination.

Authors:  T Gambichler; S Boms; S Hessam; I Tischoff; A Tannapfel; T Lüttringhaus; J Beckman; R Stranzenbach
Journal:  Br J Dermatol       Date:  2021-10-03       Impact factor: 11.113

4.  The Safety of Anti-SARS-CoV-2 Vaccines: Vigilance Is Still Required.

Authors:  Michel Goldman
Journal:  J Clin Med       Date:  2022-02-25       Impact factor: 4.241

Review 5.  SARS-CoV-2 vaccine-related cutaneous manifestations: a systematic review.

Authors:  Gianluca Avallone; Pietro Quaglino; Francesco Cavallo; Gabriele Roccuzzo; Simone Ribero; Iris Zalaudek; Claudio Conforti
Journal:  Int J Dermatol       Date:  2022-02-09       Impact factor: 3.204

6.  Rapid progression of marginal zone B-cell lymphoma after COVID-19 vaccination (BNT162b2): A case report.

Authors:  Akinori Sekizawa; Kenichi Hashimoto; Shinichi Kobayashi; Sawako Kozono; Takahiro Kobayashi; Yusuke Kawamura; Motohiro Kimata; Naoya Fujita; Yosuke Ono; Yasuhiro Obuchi; Yuji Tanaka
Journal:  Front Med (Lausanne)       Date:  2022-08-01

7.  Lymphomatoid papulosis (LyP) after AZD1222 and BNT162b2 COVID-19 vaccines.

Authors:  Dimitra Koumaki; Leonidas Marinos; Vasiliki Nikolaou; Marios Papadakis; Kyriaki Zografaki; Eleni Lagoudaki; Frantzeska-Eleni Kotopouli; Konstantinos Krasagakis; Sabine-Elke Krueger-Krasagakis
Journal:  Int J Dermatol       Date:  2022-05-18       Impact factor: 3.204

8.  Hematologic Malignancies Diagnosed in the Context of the mRNA COVID-19 Vaccination Campaign: A Report of Two Cases.

Authors:  Maria-Alexandra Zamfir; Liliana Moraru; Camelia Dobrea; Andreea-Elena Scheau; Simona Iacob; Cosmin Moldovan; Cristian Scheau; Constantin Caruntu; Ana Caruntu
Journal:  Medicina (Kaunas)       Date:  2022-06-30       Impact factor: 2.948
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.